Filter
387
Text search:
mutation
Featured
Recommendations
49
New Publications
95
Language
Document type
No document type
191
Guidelines
76
Studies & Reports
59
Manuals
18
Strategic & Response Plan
12
Fact sheets
12
Training Material
9
Videos
4
Situation Updates
3
Resource Platforms
2
Brochures
1
Countries / Regions
India
23
Global
11
Western and Central Europe
10
Africa
10
Ethiopia
9
South Africa
9
Burkina Faso
7
Cameroon
7
Latin America and the Carribbean
7
Senegal
6
Congo, Democratic Republic of
6
Haiti
6
Germany
6
Nigeria
5
Nepal
5
Tanzania
4
Benin
4
Liberia
3
Mali
3
Zambia
3
Namibia
3
Middle East and North Africa
3
Eastern Europe
3
Guinea
2
Sierra Leone
2
Côte d’Ivoire / Ivory Coast
2
Morocco
2
Uganda
2
Niger
2
Chad
2
Kenya
2
Rwanda
2
Bangladesh
2
Mozambique
2
Brazil
2
Bolivia
2
Madagascar
2
Russia
2
France
2
Saudi Arabia
1
Togo
1
Zimbabwe
1
Philippines
1
Somalia
1
Iraq
1
Jordan
1
Lebanon
1
Egypt
1
Syria
1
Cambodia
1
Thailand
1
China
1
Indonesia
1
Mauritania
1
Malawi
1
Sudan
1
Central African Republic
1
Argentina
1
Dominican Republic
1
Peru
1
Eswatini/ Swaziland
1
Cuba
1
Ukraine
1
Colombia
1
Honduras
1
Ecuador
1
Botswana
1
El Salvador
1
Libya
1
Guatemala
1
Mexico
1
Nicaragua
1
Myanmar / Burma
1
Chile
1
Yemen
1
East and Southern Africa
1
West and Central Africa
1
South–East Asia Region
1
Asia
1
Venezuela
1
Congo-Brazzaville
1
Qatar
1
Kazakhstan
1
Vietnam
1
Tunisia
1
Spain
1
Belarus
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
123
Clinical Guidelines
53
Public Health
26
Pharmacy & Technologies
13
Key Resources
8
Women & Child Health
6
Capacity Building
2
Annual Report MEDBOX
1
Toolboxes
COVID-19
65
TB
50
HIV
25
AMR
22
Rapid Response
15
Mental Health
15
Pharmacy
15
Planetary Health
11
NTDs
11
Ebola
10
NCDs
9
Refugee
7
Caregiver
6
Disability
4
Polio
2
Zika
2
Natural Hazards
1
Specific Hazards
1
A COVID-19 virus mutation tracker system (CovMT; appendix) based on SARS-CoV-2 isolate genomes deposited to GISAID to track the worldwide sequencing efforts and the evolution of the mutational landscape of this virus. CovMT, which is updated daily,
...
Lorsqu’un virus circule largement dans une population et entraîne de nombreuses infections, la probabilité de mutation augmente. Plus un virus a de possibilités de se propager, plus il se réplique – et plus il est susceptible de muter. En
...
Cystic fibrosis (CF) was earlier thought to be a disease prevalent in the West among Caucasians. However, quite a number of recent studies have uncovered CF cases outside of this region, and reported hundreds of unique and novel variant forms of CFTR. Here, we discuss the evidence of CF in parts of
...
Lorsqu’un virus circule largement dans une population et entraîne de nombreuses infections, la probabilité de mutation augmente. Plus un virus a de possibilités de se propager, plus il se réplique – et plus il est susceptible de muter. L
...
n light of the potential risk posed by SARS-CoV-2 variants, in January 2021 WHO organized an ad hoc consultation to discuss the development of an R&D agenda in response to existing and emerging SARS-CoV-2 variants.
The key objectives were to identify the critical research questions related to var
...
doi: https://doi.org/10.1101/2020.10.28.20221143
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
This technical guidance aims to provide guidelines to laboratories and relevant stakeholders in the European Union (EU), European Economic Area (EEA) and other countries in the WHO European region in making decisions on establishing sequencing capacities and capabilities, in making decisions on whic
...
The reports bring together the latest findings and conclusions about the state of resistance to artemisinins and artemisinin-based combination therapy (ACT), summarize WHO’s current policy and treatment recommendations, and highlight areas of concern.
Vertreter besorgniserregender Virusvarianten (variants of concern, kurz VOC) wurden weltweit aber auch in Europa, identifiziert. Molekularbiologische Details zu den Varianten sind unter SARS-CoV-2: Virologische Basisdaten und Virusvarianten abrufbar.
This study consists of a descriptive analysis of M. tuberculosis isolates from Beira Central Hospital, Mozambique, during 2014–2015, being the first report of a genotypic testing used to provide information about second line drug resistance in Mozambique.
BMC Infectious Diseases (2016) 16:423 DO
...
Provide guidance to HIV care practitioners on the optimal use of antiretroviral (ARV) agents for the treatment of HIV infection in adults and adolescents.
Les maladies infectieuses sont en constante mutation. De nouvelles maladies apparaissent, d’autres qui sont bien connues se propagent ou refont surface, et quelques rares fois, une maladie est éradiquée. Les maladies infectieuses telles que le V
...
Responding to a polio outbreak. Guidelines
recommended
The occurrence of a case of wild polio in a previously polio free area as presently in Syria, whether through importation, laboratory accident, or mutation of vaccine virus (VDPV), should be considered a public health emergency, that requires a rapi
...
